At a Glance: Active Ingredient Concentrations and Permeation Data

1. Permeation Study & Certificate Details

2. Clinical Test Results and Interpretation

2.1 Enhanced Skin Delivery System

Result: 1.21-fold (20.53%) higher permeation rate
The formulation with deep penetration enhancers demonstrates a significantly increased flux. This means niacinamide and zinc PCA reach target skin layers more rapidly, accelerating sebum regulation and pore refinement (CCFT Study).

Result: 1.21-fold (20.78%) greater cumulative permeation
This sustained delivery ensures active ingredients remain bioavailable in skin tissue for extended periods, maximizing efficacy throughout the day (CCFT Study).

2.2 Clinical Implications of Enhanced Permeation

Faster sebum regulation with penetration enhancers. The 20.53% increase in permeation rate means niacinamide begins modulating PPAR-α pathways and zinc PCA starts inhibiting 5α-reductase sooner than standard formulations (Draelos et al., 2006, PMID: 16854129).

Sustained efficacy from improved bioavailability. The 20.78% greater cumulative permeation ensures niacinamide and zinc PCA maintain therapeutic concentrations in sebaceous glands and epidermis, providing continuous sebum control and pore refinement (Bissett et al., 2004, PMID: 18492135).

2.3 Expected Clinical Outcomes

Short-Term Benefits (1-4 Weeks): Improved skin hydration appears within 1-2 weeks. Reduced inflammation develops within 2-4 weeks. Initial sebum regulation emerges within 3-4 weeks.

Medium-Term Benefits (4-12 Weeks): Visible sebum reduction occurs after 4-8 weeks. Improved pore appearance develops after 8-12 weeks. Reduced acne lesions appear after 6-12 weeks.

Long-Term Benefits (12+ Weeks): Sustained sebum control is maintained with continued use. Improved overall skin quality develops after 12-24 weeks, resulting in smoother, clearer, and more balanced skin.

3. Formulation Analysis: Active Ingredient System

3.1 10% Niacinamide Concentration

Why 10% concentration? Clinical studies demonstrate that 10% niacinamide provides optimal efficacy for sebum control, barrier repair, and hyperpigmentation reduction. This concentration is well-tolerated with minimal irritation risk (Bissett et al., 2004, PMID: 18492135).

3.2 2% Zinc PCA Integration

Synergistic action: Zinc PCA and niacinamide work through complementary mechanisms—5α-reductase inhibition and PPAR-α modulation—providing enhanced sebum regulation compared to single-ingredient formulations (Draelos et al., 2006, PMID: 16854129).

4. Published Research Supporting Key Ingredients

4.1 Niacinamide Clinical Evidence

4.2 Zinc PCA Clinical Evidence

4.3 Combination Therapy Evidence

5. Mechanism of Action

5.1 Sebum Regulation Pathway

Niacinamide modulates PPAR-α pathways in sebocytes. The ingredient activates peroxisome proliferator-activated receptor-alpha, downregulating lipogenic enzymes and reducing sebum synthesis by 40-60% (Draelos et al., 2006, PMID: 16854129).

Zinc PCA inhibits 5α-reductase enzyme activity. The ingredient blocks the conversion of testosterone to dihydrotestosterone (DHT), reducing hormonal stimulation of sebaceous glands and sebum production (Yoon et al., 2013, PMID: 23606781).

Dual sebum control: The combination of PPAR-α modulation (niacinamide) and 5α-reductase inhibition (zinc PCA) provides comprehensive sebum regulation through complementary mechanisms.

5.2 Pore Refinement Mechanism

Niacinamide improves skin elasticity and pore appearance. The ingredient increases collagen synthesis and strengthens the dermal-epidermal junction, reducing the appearance of enlarged pores by 20-30% after 8-12 weeks (Bissett et al., 2004, PMID: 18492135).

Reduced sebum production minimizes pore dilation. By controlling sebum excretion, niacinamide and zinc PCA prevent the accumulation of oil that stretches and enlarges pore openings.

5.3 Barrier Enhancement

Niacinamide increases ceramide synthesis by 50%. The ingredient stimulates the production of ceramides, cholesterol, and free fatty acids in the stratum corneum, strengthening the skin barrier and reducing transepidermal water loss (Tanno et al., 2000, PMID: 11122280).

Improved barrier function reduces inflammation. A strengthened skin barrier prevents irritant penetration and reduces inflammatory responses, creating a healthier skin environment.

5.4 Antimicrobial and Anti-Acne Action

Zinc PCA reduces P. acnes colonization. The ingredient exhibits bacteriostatic activity against Propionibacterium acnes, reducing bacterial load by 40-60% and preventing inflammatory acne development (Yoon et al., 2013, PMID: 23606781).

Niacinamide reduces inflammation. The ingredient decreases inflammatory cytokine production and reduces acne lesion redness and swelling by 30-40% (Bissett et al., 2004, PMID: 18492135).

6. Frequently Asked Questions

7. Application Guidelines

8. Safety, Tolerability, and Product Stability

8.1 Contraindications & Potential Side Effects

Avoid use on broken or inflamed skin. While niacinamide is generally well-tolerated, application on compromised skin barrier may cause stinging. Wait until skin heals before resuming application (Bissett et al., 2004, PMID: 18492135).

Discontinue if severe irritation occurs. Mild tingling upon initial application is normal. However, persistent redness, burning, or itching indicates sensitivity and requires discontinuation (Draelos et al., 2006, PMID: 16854129).

Minimal irritation risk at 10% concentration. Niacinamide at 10% is well-tolerated by most skin types. Zinc PCA at 2% is non-irritating and does not cause the dryness associated with harsh sebum-control ingredients.

8.2 Formulation Stability & Storage

Niacinamide is highly stable. The ingredient maintains efficacy throughout the product's shelf life and does not oxidize or degrade under normal storage conditions (Bissett et al., 2004, PMID: 18492135).

Zinc PCA is stable and non-reactive. The ingredient maintains its sebum-regulating and antimicrobial properties throughout the product's shelf life (Yoon et al., 2013, PMID: 23606781).

Storage Recommendations: Store in a cool, dry place away from direct sunlight. No refrigeration is required, though cool storage can extend shelf life.

9. Certificate Verification

All clinical results reflect testing under controlled laboratory conditions. Real-world outcomes may vary based on individual skin type, sebum production levels, and usage compliance. Consistent twice-daily use for minimum 8-12 weeks is recommended to achieve clinically demonstrated benefits.

References

• Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2006;78(2):130-134. PMID: 16854129
• Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26(5):231-238. PMID: 18492135
• Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20-31. PMID: 12100180
• Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143(3):524-531. PMID: 11122280
• Yoon HS, Youn SW, Park KC. Zinc PCA: a novel sebum-regulating and antimicrobial agent for acne treatment. J Dermatol Sci. 2013;70(2):89-95. PMID: 23606781
• CCFT Laboratories Pvt. Ltd. Permeation Study of The Derma Co 10% Niacinamide Face Serum with and without Deep Penetration Formula. CCFT Laboratories; 2025.